MEDINDIA
English
हिन्दी
Español
français
中文
Professor Vincent Marks, a leading authority on the forensic aspects ofhypoglycemia and its role in criminal behavior, discusses howhypoglycemia-related neuroglycopenia can cause behavioral changes, which canbring people with diabetes into conflict with the law. "Hypoglycemia wasrecognized as a cause of strange behavior that amounted in some cases tocriminality, within a few years of the introduction of insulin for treatmentof diabetes", comments Professor Marks. He raises the question of whether aperson suffering from neuroglycopenia can formulate the intention to commitan offence, going on to outline the medico-legal relevance of hypoglycemia,and to discuss the less common offence of malicious administration of insulinand/or a sulfonylurea as a weapon to induce hypoglycemic coma.
Professor Brian Frier's related editorial describes the problem ofmanaging diabetes in people in police custody or long-term imprisonment.Highlighting the fact that custodial conditions can be conducive to thedevelopment of hypoglycemia in people with diabetes, Professor Frier suggeststhat greater communication between diabetes specialist services and thepolice and prison services should be encouraged, to assist theirunderstanding of this medical disorder and avoid the development ofsignificant hypoglycemia and perpetuation of suboptimal glycemic control insuch situations.
About Diabetic Hypoglycemia
We are pleased to announce that Diabetic Hypoglycemia will be indexed inElsevier's prestigious EMBASE database, from 2010.
Diabetic Hypoglycemia is an influential online diabetes journal led byEditor-in-Chief Professor Brian Frier (Edinburgh, UK), with AssociateEditors: Professor Simon Heller (Sheffield, UK), Professor Christopher Ryan(Pittsburgh, USA) and Dr Rory McCrimmon (Dundee, UK). Published three timesannually, Diabetic Hypoglycemia provides an interactive forum for the sharingof practical knowledge and opinions in the field of hypoglycemia.
To explore Diabetic Hypoglycemia, please take the guided tour:http://www.hypodiab.com/Teaser/hypodiab.html.
Diabetic Hypoglycemia is published by ESP Bioscience, supported by anunrestricted educational grant from Novo Nordisk A/S (Bagsvaerd, Denmark).
About ESP Bioscience
ESP Bioscience is a publisher of novel medical information products andonline medical communities, with headquarters in Sandhurst, United Kingdom.Working in association with its academic partners in the global healthcarecommunity, ESP Bioscience publishes journals, books and online resources.Contact: Editorial Office E: [email protected] T: +44-(0)1344-762531 F: +44-(0)203-0514753
SOURCE ESP Bioscience
